Abvc Biopharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.05

-0.08 (-7.08%)

As of Sep 28, 10:31 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +2,252.4% upside

Low Target $17.28

Average Target $24.70

High Target $43.03

Current Price $1.05

Current
$1.05

Target
$24.70

$17.28 $24.70 avg $43.03

Scenario Analysis

Bear Case

$17.28

1,545.7%

Low target

Base Case

$24.70

+2,252.4%

Avg target

Bull Case

$43.03

+3,998.1%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$3.40

-69.1% from high

52-Week Low

$0.71

+48.5% from low

Target vs 52W High

$24.70

+626.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-26.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.2%